Top compounds associated with response to GLP2R


Feature Type Standardized
Nominal ANOVA
mRNA VX-11e GDSC1000 pan-cancer AAC -0.058 0.08
mRNA ELCPK CTRPv2 pan-cancer AAC -0.088 0.08
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.061 0.08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.064 0.08
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.07 0.08
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.063 0.08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.08
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.058 0.09
mRNA tivantinib CTRPv2 pan-cancer AAC -0.077 0.09
Download CSV